MEIP Kacepetan wutah bathi saben saham ing taun lumaku MEI Pharma Corporation

Simbol resmi perusahaan MEI Pharma Corporation (MEIP)

The annual EPS growth rate on the GURU.Markets website helps assess the potential of MEI Pharma, Inc. (MEIP), which develops innovative blood therapy methods. However, the risk of clinical trial failure creates high volatility. Current cash pressure and the depletion of reserves in the absence of sales exacerbate the situation, while 0.00 represents the latest level value, allowing for the timely detection of the issuer's financial instability.

MEIP - Wutah bathi saben saham ing taun lumaku MEI Pharma Corp ing rentang 04.07.2022 - 11.09.2025

Rincian metrik keuangan lan pasar MEI Pharma, Inc. (MEIP)

- nilai saham lan prakiraan konsensus rega:
Rega bursa MEI Pharma Inc|MEIP - Bagan rega target
- data kapitalisasi pasar:
Nilai pasar MEI Pharma Corporation|MEIP - Nilai Perusahaan
- data ekuitas miturut neraca:
Ekuitas saben Saham MEI Pharma|MEIP - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Aset Bersih meipharma.com|MEIP - Total Aset Perusahaan
- indikator beban utang lan likuiditas:
Utang marang Modal MEI Pharma, Inc.|MEIP - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal meipharma.com|MEIP - Gunggung utang perusahaan|Rasio utang marang aset resik MEI Pharma Corporation|MEIP - Utang jangka dawa perusahaan|Kewajiban jangka cendhak MEI Pharma|Rasio jangkoan perantara meipharma.com
- statistik bathi lan rasio pasar:
MEIP - Bathi resik|Proyeksi bathi mangsa ngarep MEI Pharma, Inc.|MEIP - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi MEI Pharma Corporation|MEIP - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan MEI Pharma Corporation|MEIP - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) MEI Pharma|MEIP - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan meipharma.com|MEIP - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep MEI Pharma, Inc.
Ringkesan analisis perusahaan:MEI Pharma Inc (MEIP)
Produk mawa merek MEI Pharma

To identify the fundamental drivers of stability for MEI Pharma, Inc. (MEIP), it is critical to analyze the dynamics of net earnings per share. This 12-month EPS growth percentage is calculated as the ratio of the current value to the same period last year, reflecting the actual efficiency of capitalization. For a developer of blood cancer therapies, such a metric confirms the ability to monetize the shortage of effective treatments in oncohematology.

Pesaing utama

Kacepetan wutah bathi saben saham ing taun lumaku TG Therapeutics Inc (TGTX)|Wutah bathi saben saham ing taun lumaku Arcellx Corp|Kacepetan wutah bathi saben saham ing taun lumaku Disc Medicine Pharma IRON|Wutah bathi ing taun lumaku SNDX|kuraoncology.com - Wutah bathi saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku ADC Therapeutics SA ADCT|FHTX - Wutah bathi resik saben saham ing taun iki|Vor Bio - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Nkarta, Inc.|COEP: Wutah bathi ing taun lumaku|ATNM - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben saham ing taun iki ESLA|CASI: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Marker Therapeutics (MRKR)|INAB: Dinamika bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku ERNA (Eterna Therapeutics Inc.)|Tambahing bathi saben saham ing taun lumaku GTBP|Aptose - Wutah bathi ing taun lumaku|BPTH - Wutah bathi ing taun lumaku|vincerx.com (VINC) - Wutah bathi saben saham ing taun lumaku